您的购物车当前为空
SMER28 是一种自噬小分子增强剂,通过不依赖于 mTOR 的机制诱导哺乳动物细胞中独立于雷帕霉素的自噬,并阻止淀粉样蛋白 β 肽的积累。


为众多的药物研发团队赋能,
让新药发现更简单!
SMER28 是一种自噬小分子增强剂,通过不依赖于 mTOR 的机制诱导哺乳动物细胞中独立于雷帕霉素的自噬,并阻止淀粉样蛋白 β 肽的积累。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 192 | In Stock | |
| 5 mg | ¥ 413 | In Stock | |
| 10 mg | ¥ 578 | In Stock | |
| 25 mg | ¥ 1,160 | In Stock | |
| 50 mg | ¥ 2,230 | In Stock | |
| 100 mg | ¥ 3,390 | In Stock | |
| 200 mg | ¥ 4,920 | In Stock | |
| 500 mg | ¥ 7,730 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 455 | In Stock |
SMER28 相关产品
| 产品描述 | SMER28 is a small-molecule enhancer (SMER) of autophagy, inducing autophagy independently of rapamycin in mammalian cells via an mTOR-independent mechanism and prevented the accumulation of amyloid beta peptide. |
| 体外活性 | SMER28是一种促进自噬作用的积极调节剂,其机制独立于mTOR途径。它增加了自噬体的合成,并提高了如A53T α-突触核蛋白和突变亨廷顿蛋白片段等模型自噬底物的清除能力。SMER28还能显著降低Aβ/APP-CTF水平,并通过自噬途径增强Aβ/APP-CTF的降解。在SMER28处理[1]后,APP-CTF和LC3-II在同一区室内共定位。 |
| 细胞实验 | MEF cells overexpressing βCTF are treated with autophagy-enhancing compounds (10 μM) for 16 h. Cell lysates are analyzed by SDS-PAGE and Western blotting using anti-βCTF (6E10) and anti-tubulin antibodies.(Only for Reference) |
| 分子量 | 264.12 |
| 分子式 | C11H10BrN3 |
| CAS No. | 307538-42-7 |
| Smiles | BrC1=CC=C2N=CN=C(NCC=C)C2=C1 |
| 密度 | 1.520 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 60 mg/mL (227.17 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (7.57 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容